Abstract
Peste des petits ruminants virus (PPRV) is known to replicate in a wide variety of ruminants causing very species-specific clinical symptoms. Small ruminants (goats and sheep) are susceptible to disease while domesticated cattle and buffalo are dead-end hosts and do not display clinical symptoms. Understanding the host factors that influence differential pathogenesis and disease susceptibility could help the development of better diagnostics and control measures. To study this, we generated transcriptome data from goat and cattle peripheral blood mononuclear cells (PBMC) experimentally infected with PPRV in-vitro. After identifying differentially expressed genes, we further analyzed these immune related pathway genes using the Search Tool for the Retrieval of Interacting Genes/Proteins (STRING) and selected candidate genes were validated using in-vitro experiments. Upon PPRV infection, we identified 12 and 22 immune related genes that were differentially expressed in goat and cattle respectively. In both species, this included the interferon stimulated genes (ISGs) IFI44, IFI6, IFIT1, IFIT2, IFIT3, ISG15, Mx1, Mx2, OAS1X, RSAD2, IRF7, DDX58 and DHX58 that were transcribed significantly higher in cattle. PPRV replication in goat PBMCs significantly increased the expression of phosphodiesterase 12 (PDE12), a 2′,5′-oligoadenylate degrading enzyme that contributes to the reduced modulation of interferon-regulated gene targets. Finally, a model is proposed for the differential susceptibility between large and small ruminants based on the expression levels of type-I interferons, ISGs and effector molecules.
Keywords: RNAseq, differential PPR disease resistance, differentially expressed, interferon stimulated genes (ISGs), PDE12
1. Introduction
Peste des petits ruminant’s virus (PPRV), a morbillivirus in the family Paramyxoviridae, causes an acute, extremely contagious disease. Ovine rinderpest or goat plaque is characterized by high fever, ocular and nasal discharges, pneumonia, necrotic and inflammation and ulcerative lesion of the mucosa in the gastrointestinal tract [1]. PPRV was first reported in India in 1989 and subsequently spread all over the country [2,3,4,5]. In India, the disease is mainly controlled through the use of a Vero cell-attenuated Sungri 96 vaccine which elicits a protective antibody response forup to 78 months [6]. PPRV infection is usually confined to populations of small ruminants with particular breeds of goats being reported as more susceptible than others [7] and with more severe pathology compared to sheep [8,9]. Differential disease resistance to PPRV has been reported both at the species and breed levels; the Guinean breeds (West African dwarf (WAD), Iogoon, Kindi and Djallonke) are known to be highly susceptible [7].
Although Cattle can become infected with PPRV, unlike the closely related rinderpest virus (RPV), they do not show clinical signs and are not susceptible to disease [7,10]. However, virus replication and sero-conversion does occur in large ruminants [11]. Interestingly, a clinical case of PPRV infection was reported following experimental inoculation of calves [12] and another report describes that PPRV was isolated from an RPV-like outbreak in Indian buffaloes [13]. PPRV was also suspected to be involved in the epizootic disease that affected one-humped camels in Ethiopia in 1995–1996 [14] with detection of PPRV antigen and nucleic acid in some of the pathological samples, but no live virus was isolated.
The genetics underlying this host-specific disease resistance to PPR is unknown. The two likely mechanisms are the differential presence or expression of viral specific receptors or the nature and type of the immune response. The signaling lymphocyte activation molecule (SLAM) a cellular receptor for PPRV, its expression level and PPRV replication rates have been shown to be highly correlated [15]. Furthermore, different levels of SLAM mRNA correlated with virus replication in different species such as cattle, buffalo, goat and sheep. In addition to SLAM, ovine nectin-4 was identified as a novel epithelial receptor for PPRV, which determines tissue distribution and pathogenicity [16]. The replication of PPRV in the PBMC of Indian domestic goats and water buffalo is influenced by the expression levels of TLR3, TLR7 and downstream signaling molecules. Upon stimulation of PBMC with synthetic TLR3 and TLR7 agonists or PPRV, the levels of pro-inflammatory cytokines were found to be significantly different across goats and water buffalo, a likely mechanism influencing differential susceptibility to disease [17]. In contrast, immunosuppressive interleukin (IL) 10 levels were lower in PPR-resistant Kanni and Salem Black breeds of goat and water buffalo at the transcriptional level, correlating with reduced viral loads in infected PBMC. In addition, water buffalo also produced higher levels of interferon alpha (IFNα) in comparison with goats both at transcriptional and translational levels which were confirmed to be TLR7 mediated through inhibitor and pre-treatment studies [17]. Thus, differential gene expression analysis can be a very powerful first attempt to correlate immune responses with gene regulation. Such approaches can also identify potential target genes for disease control.
Earlier studies used candidate gene-based approaches (individual genes or proteins one at a time) to understand the host and pathogen interactions. To gain a more global understanding of gene expression underlying differential responses to PPRV infection, we used an RNAseq approach to study the transcriptome of goat and cattle PBMC exposed to PPRV in vitro. This systems biology approach may be useful in understanding differences in susceptibility toPPR in different animal species, identifying early markers of infection, potential antiviral targets and for understanding the basic molecular mechanisms of host-virus interactions.
2. Materials and Methods
2.1. Samples Used in the Study
Blood samples for isolation of PBMC were collected from clinically healthy goats (Kanni cross, n = 6) and cattle (HF cross, n = 6) maintained at University Research Farm, Centre for Animal Production Studies, TANUVAS, Madhavaram Milk Colony, Chennai-51. These animals were not vaccinated for PPRV and sero-negativity was confirmed with an ID Screen PPR competition ELISA kit (ID.vet, Montpellier, France). The PPRV strain used for infection of PBMC was IND/TN/VM/2014/02 (at 10th passage level in Vero cells; GenBank Accession No. KT860063.1) for 24 h at different 1 MOI. RNAseq data was generated from two replicate PBMC samples from each individual in each species to act as biological replicates. Replicate samples from three animals were pooled together resulting in two samples from each species, control and PPRV infected.
2.2. RNA Isolation, Library Preparation and Sequencing
Twenty-four hours post infection was chosen as the most meaningful time point to study gene expression based on the replication kinetics data from our earlier studies with goats and buffalo PBMC [17] as well as those experiments with cattle and goat PBMC (Supplementary information—PPRV replication kinetics). RNAwas extracted from PBMC samples from each sample/species separately using Trizol as per the manufacturer’s instructions and cleaned up using RNeasy Mini kit (Qiagen, India) with DNAse I treatment. The RNA quality was assessed in Qubit® 2.0 Fluorometer with the Qubit® RNA BR Assay Kit (Life Technologies, Carlsbad CA, USA) and on a 2100 Bioanalyzer using an Agilent RNA 6000 Pico Kit (Agilent Technologies, Carlsbad CA, USA). For further processing, the RNA integrity number (RIN) values for all the samples were ascertained to be more than 9.0, the Ribo-Zero rRNA removal kit (Cat no. MRZH116, Illumina) was used to deplete ribosomal RNA with the protocol modified to suit the different RNA input amounts, the depleted RNA was purified with the RNA Clean and Concentrator–5 kit (Zymo Research, Irvine, CA, USA) to retain more than >17 nt RNA fragments and eluted in nuclease-free water. Libraries were constructed using depleted RNA obtained from total RNA using the TruSeq stranded mRNA sample preparation kit (Illumina, San Diego, CA, USA) with the depleted RNA introduced in the RNA fragmentation and priming step and the remaining steps performed as per the manufacturer’s protocols. The high-throughput paired-end sequencing was carried out on the Illumina HiSeq 2000 platform. The data generated from the two replicates (control and infected across both the species) were analyzed separately under the bioinformatic analysis projects P4365 and P4117 as provided in the results.
2.3. Bioinformatic Analysis of the Sequence Data
2.3.1. Quality Check and Assembly
A read quality check on the fastq file of the different samples was performed (which included base quality and sequence quality score distribution, read length and GC distribution, PCR amplification issues, any over-represented sequences and biasing of kmers) and sequences trimmed to retain high quality reads. Unwanted sequence including non-polyA tailed RNAs, mitochondrial genome sequence, transfer RNAs, adapter sequences and others were removed by using Cutadapt (V 1.8) and bowtie2 (version 2.2.2), in-house Perl scripts and picard tools (version 1.115). For the data generated from cattle PBMC (un-infected and PPRV infected) the Bos taurus reference genome and gene model downloaded from Ensembl database (ftp://ftp.ensembl.org/pub/release83/gtf/bos_taurus/Bos_taurus.UMD3.1.83.gtf.gz) and the pre-processed reads were then aligned using Tophat program (version 2.1.0; default parameters). After alignment with reference gene model, the aligned reads were used for estimating expression of the genes and transcripts, using cufflinks program (version 2.2.1). An in-house Perl script was used to generate a list of all detected splice junctions in the sample and the transcripts were scored differentially expressed at a p value of ≤0.01. Efficient and robust de novo reconstruction of the transcriptomes was also performed on the RNAseq data of goat PBMC (un-infected and PPRV infected) using Trinity (http://www.cs.huji.ac.il) with default settings. The trimmed reads were aligned to the assembled transcriptome using Bowtie2 programand the expression value as Fragments Per Kilo base of transcript per Million mapped reads (FPKM) distribution determined. For downstream annotation, we focusedonlyonthesetranscripts. The list of software, their version, source link and the purpose are listed in Supplementary Table (Table S1).
2.3.2. Transcriptome Annotation, Differential Gene Expression Analysis and Protein-Protein Interactions
The assembled transcripts were compared with NCBI non-redundant protein database using BLASTX program. Matches with E-value ≤ 10−5 and similarity score ≥40% were retained for further annotation. The BLASTX summary is provided separately along with the e-value distribution. Around 58% of the transcripts identified using BLASTX have confidence level of at least 1 × 10−5, which indicates high protein conservation. The predicted proteins from BLASTX were annotated against NCBI, UniProt, Pathway and Swiss-Prot. The complete annotation is divided into three categories; gene, protein and gene ontology annotation. The aligned and annotated reads were also used for estimating expression of the genes and transcripts using cufflinks program (version 2.2.1) which provided data on gene and isoform expression in all the samples. The differential gene expression analysis was performed using the Cuffdiff program of cufflinks package and an FPKM > 1 for at least one of the two samples being compared with p-values of 0.01 and 0.05 separately were used as cut-off for up and down-regulated genes and isoforms respectively. The total number of transcripts mapping to some of the important sub-categories under the biological process (based on previous data) were selected for further analysis and validation to determine the differential expression across goats and cattle upon exposure to PPRV. Differentially expressed genes were submitted to the Search Tool for the Retrieval of Interacting Genes/Proteins (STRING) database (version 10.5) to identify the protein-protein interactions (PPI) and the network and spectrum of the gene interactome.
2.3.3. Validation of the Differential Targets Identified in RNAseq Data
Differentially expressed transcripts between goat and cattle identified in the RNAseq data were selected for validation by real-time PCR using SYBR Green chemistry. The selection of the transcripts was based on our previous report (differential interferon response as reported by Dhanasekaran et al., 2014) [17] as well as the PPI predicted by the STRING analysis. The real-time PCR (RT-qPCR) primers for the different targets were designed using the online tool Primer3 Input (version 4.0) targeting conserved regions across goat and cattle (Table 1). For this purpose, RNA was extracted from control and infected (1 MOI of PPRV) cattle and goat PBMC (n = 5) after 24 h to reinforce the significance and repeatability of the findings (refer Supplementary Information—PPRV replication kinetics) and cDNA was synthesized using the High-Capacity cDNA Reverse Transcription Kit with RNase Inhibitor (Thermo Fischer Scientific). Each sample was assayed in triplicate and expression levels were calculated as mean fold change 2−∆∆Ct over the respective basal levels of each control sample. The RT-qPCR expression levels were considered significantly different if the p value was <0.05 and the results were also compared with the differential expression results predicted from the Cuffdiff analysis of the RNAseq data.
Table 1.
Gene Target | Sequence (5′----->3′) | Nucleotide Position | Product Size |
---|---|---|---|
PPRV-M-F | AGTGATTGAGGATAACGAC | 3608–3627 | 242 bp |
PPRV-M-R | TTAGCGCTAAACACACTTCC | 3850–3830 | |
β-actin F | GGCTGTGCTGTCCCTGTAC | 156–174 | 156 bp |
β-actin R | CCGGAGTCCATCACGATGC | 214–194 | |
GAPDHF | GGCGTGAACCACGAGAAGTATAA | 470–492 | 119 bp |
GAPDHR | CCCTCCACGATGCCAAAGT | 588–570 | |
DHX58F | GGGACATGCTGAAGAAGCTC | 723–742 | 175 bp |
DHX58R | TTGTACCGACGCAGATGAAG | 897–878 | |
IFI44F | GTCCATGTGGTGTTGCTCAC | 1157–1176 | 180 bp |
IFI44R | CTCCAGTTCCCACTCTGAGG | 1336–1317 | |
IFI6F | AACTCGT/GTGGCCTCCTCAC | 524–542 | 168 bp |
IFI6R | TTCGACTTGCTTGTGGACAG | 691–672 | |
ISG15F | CAGTTCATCGCCCAGAAGAT | 147–166 | 171 bp |
ISG15R | GTCGTTCCTCACCAGGATGT | 317–298 | |
IFIL1F | ACTACGGCCGATTTCTGGAA | 1467–1485 | 244 bp |
IFIL1R | AGGGCCCGCTCATAATACTC | 1709–1690 | |
IFIL2F | TGCTGCTATAGGGCCAAAGT | 1084–1103 | 240 bp |
IFIL2R | CACTTGTTTGGCTACG/AGGAG | 1323–1304 | |
IFIL3F | GAGCTGGACTGTGAGGAAGG | 461–480 | 242 bp |
IFIL3R | AGGGCCAGGAGAACTTTGAT | 702–683 | |
MX1F | GTCCCTGCTAACGTGGACAT | 714–733 | 155 bp |
MX1R | ACCAGGTTTCTCACCACGTC | 868–849 | |
MX2F | GCAGATCAAGGCACTCATCA | 992–1011 | 168 bp |
MX2R | ACCAGGTCTGGTTTGGTCAG | 1159–1140 | |
OAS1XF | CTGACCTCGTCGTCTTCCTC | 260–279 | 224 |
OAS1XR | CAGGACATCGAACTCCACCT | 483–464 | |
PDE12F | GTGTTTCGAATCAAGCAGCA | 1186–1205 | 176 bp |
PDE12R | CTCTGGAGCACCCTTTCTTG | 1361–1342 | |
RSAD2F | ATTTGGACATTCTCGCCATC | 570–589 | 182 bp |
RSAD2 R | ATCCTCGTCCACGTTGAATC | 751–732 | |
DDX58F | AAGGAT/CTGCCTCCATGACTG | 2747–2766 | 164 bp |
DDX58R | GCAGCATCAAATGGGATCTT | 2910–2891 | |
IFI44LF | TTCCAAGGCCATTTGACTCG | 798–817 | 150 bp |
IFI44LR | CTCTTT/CCTCATCCAGCCCCA | 947–928 | |
IFIH1F | ATCTCGTGTTTCAGGGCCAG | 389–408 | 206 bp |
IFIH1R | AGGGCCTCTACGAACATCCT | 594–575 | |
IRF7F | TCCCCGCACTACACCATCTA | 1614–1633 | 224 bp |
IRF7R | AAGTGCTCCAGGAAGTGCTC | 1837–1818 |
These primers were used in a SYBR green based RT-qPCR to determine the expression levels of the corresponding target mRNA in the control and infected cells.
3. Results
3.1. Transcriptome Assembly, Annotation and Gene Ontology
3.1.1. Transcriptome Assembly
The generated reads from the un-infected and PPRV infected goat and cattle PBMC were analyzed as per the bioinformatics workflow depicted in Figure 1. Raw reads were subjected to adapter and end trimming, filtering low quality data (Q < 20), discarding read length < 30 and contamination removal before assembly. The number of quality passed paired end reads was between 23.6 M to 30 M and 25.6 M to 25.9 M from each of the goat and cattle PBMC samples respectively(both un-infected and PPRV infected (Table 2). An average of 91.13% of the reads generated from each of the cattle and goat PBMC samplespassed at ≥30 Phred score (submitted to the Sequence Read Archive (SRA) database (BioProject ID-PRJNA615772)). The percentage of cattle reads aligning to the Bos taurus genome was 71.61% and 90.11% while de-novo assembly of the goat PBMC reads resulted in 86.83% and 87.77% alignment (meets the requirements as per the guidelines of ENCODE). The details pertaining to the quality passed reads, quality scores and the alignment count from the replicate (Bioinformatic analysis—P4117) are listed in Table 2.
Table 2.
Sample/SRA BioSample ID/SRA ID | No. of Paired End Reads and No. of Bases (Gb) | Aligned Read Count and Percent Aligned | % Q > 30 | Number of Transcripts with FPKM ≥ 1.0 |
---|---|---|---|---|
NGS data generated from the Project–P4365 | ||||
Goat_4-Control: [BioSample ID–SAMN14478390 & SRA ID–SRR11440511] | 23,662,652 (4.73 Gb) | 14,740,174 (86.83%) | 90.62 | 179,233 ** |
Goat_3- PPRV Infected: [BioSample ID–SAMN14469261 & SRA ID–SRR11434618] | 30,098,206 (6.01 Gb) | 18,537,737 (87.77%) | 91.36 | 150,093 ** |
Cattle_4- Control: [BioSample ID–SAMN14480722 & SRA ID–SRR11442915] | 25,656,128 (5.131 Gb) | 44,579,027 (90.11%) | 91.3 | 11503 |
Cattle_3- PPRVInfected: [BioSample ID–SAMN14480403 & SRA ID–SRR11442832] | 25,995,419 (5.199 Gb) | 36,088,556 (71.61%) | 91.25 | 11633 |
NGS data generated from the Project–P4117 | ||||
Goat_2-Control: [BioSample ID–SAMN14492330 & SRA ID–SRR11431701] | 18,315,355 (3.66 Gb) | 13,017,046 (89.76%) | 87.95 | 83,315 ** |
Goat_1-PPRV Infected: [BioSample ID–SAMN14466456 & SRA ID–SRR11431292] | 27,803,932 (3.54 Gb) | 17,955,944 (88.27%) | 87.87 | 71,874 ** |
Cattle_2-Control: [BioSample ID–SAMN14480879 & SRA ID–SRR11443109] | 24,457,636 (3.08 Gb) | 19,605,498 (63.68%) | 87.54 | 10,414 |
Cattle_1-PPRV infected: [BioSample ID–SAMN14478687 & SRA ID–SRR11440572] | 25,055,747 (3.23 Gb) | 14,281,792 (57.00%) | 89.64 | 10,356 |
SRA—Sequence Read Archive; FPKM—Fragments Per Kilo base of transcript per Million mapped reads; Project P4365—next generation sequencing to generate RNAseq data from the PBMC of goat and cattle (control and PPRV infected (replicate-1)); Project P4117—next generation sequencing to generate RNAseq data from the PBMC of goat and cattle (control and PPRV infected (replicate-2)); The raw reads generated for this project has been submitted to the NCBI SRA database under the BioProject ID–PRJNA615772 (the details on the BioSample ID and SRA ID are listed below each of the sample); These reads were subjected to adapter and end trimming, filtering low quality data (Q < 20), discarding read length < 30 and contamination removal before assembly and further analysis. The percent of the aligned read count for the samples to the genome are well within the requirements suggested by ENCODE consortium; **—transcripts predicted by de-novo assembly (due to non-availability of a completely annotated goat genome) and hence the number of transcripts with FPKM ≥ 1.0 is higher in the goat reads annotated.
3.1.2. Annotation:
With a minimum cut off value of ≥1 fragmentper kb of transcript per million mapped reads (FPKM) we could identify 352,462 transcripts with a read length of ≥200 bases (Table 3). The assembled transcripts were compared with the Mammalia protein database downloaded from Uniprot using the BLASTX program. The contigs without annotation were separated and compared with NCBI non-redundant protein database and matches with E-value ≤ 10−5 and similarity score ≥ 40% were retained for further annotation. We identified 50,063 (46.50%) assembled unique transcripts (longest identified transcript was 23,114 bases) withat least one significant hit in NCBI database (both BLASX and Uniprot) out of 352,462 predicted transcripts (length ≥ 200bp; FPKM ≥ 1.0) (Table 3). The BLASTX search E-value and the similarity score distribution is provided in Figure S1 and around 57%–58% of the transcripts identified using BLASTX had a confidence level of atleast 1e-5. We observed that 93% to 95% transcripts identified in BLASTX had a similarity of more than 60% at protein level indicating greater protein level conservation.
Table 3.
FPKM | Number of Transcripts (P4365) * | Number of Transcripts (P4117) * | ||||||
---|---|---|---|---|---|---|---|---|
Goat_4 Cont. ** | Goat_3 PPRV Inf. ** | Cattle_4Cont. | Cattle_3 PRV Inf. | Goat_2 Cont. ** | Goat_1 PPRV Inf. ** | Cattle_2Cont. | Cattle_1PRV Inf. | |
1–2 | 89,644 | 73,363 | 959 | 1048 | 44,664 | 32,444 | 1128 | 1111 |
2–5 | 46,460 | 37,026 | 1753 | 1706 | 16,919 | 17,975 | 2238 | 2287 |
5–10 | 17,944 | 17,794 | 1933 | 1914 | 9644 | 9809 | 2267 | 2215 |
10–20 | 14,126 | 12,592 | 2338 | 2398 | 6500 | 6250 | 2160 | 2000 |
20–50 | 8425 | 6863 | 2723 | 2700 | 3775 | 3522 | 1668 | 1611 |
50–100 | 1665 | 1524 | 978 | 1013 | 992 | 1009 | 473 | 561 |
≥100 | 969 | 931 | 819 | 854 | 821 | 865 | 480 | 571 |
Total | 179,233 | 150,093 | 11,503 | 11,633 | 83,315 | 71,874 | 10,414 | 10,356 |
3,52,462 assembled transcripts (longest transcript 23,144 bases) | 1,75,959 assembled transcripts (longest transcript 30,976 bases) |
Project P4365—next generation sequencing to generate RNAseq data from the PBMC of goat and cattle (control and PPRV infected (technical replicate-1). The raw reads generated for this project has been submitted to the NCBI SRA database under the BioProject ID—PRJNA615772 (the details on the BioSample ID and SRA ID are listed in Table 2); * Read length ≥200 bases; **: transcripts predicted by de-novo assembly and number of transcripts with FPKM ≥ 1.0 is higher in the goat reads annotated.
3.1.3. Gene Ontology
Gene ontology (GO) analyses of the annotated transcripts were under taken as it indicates likely gene functions across cellular components, molecular functions and biological processes at a p-value ≤ 0.05. The total number of GO different terms identified across biological process, molecular function and cellular component included 33,412 (with 118,736 transcripts), 11,323 (with 71,161 transcripts) and 14,076 (with 81,646 transcripts) respectively. The top 15 terms in each of the above categories are depicted in Figure S1 (for detailed summary on the GO terms refer Supplementary Table; Table S2).
3.2. Functional Analysis of Differentially Expressed Genes across Goat and Cattle upon Exposure to PPRV
One of the major applications of RNAseq experiments is a measure of the relative abundance of different transcripts (as FPKM) from the sequenced reads generated after transcriptome assembly. Differential gene expression analysis between goat and cattle before and after PPRV exposure was performed using the Cufflinks program. The gene-expression distribution in FPKM across the different samples is shown in Table 3, and confirms that even the low expressed transcripts (<100 FPKM) have been detected effectively in the data generated using both the reference genome (for cattle samples) and de-novo assembly (for goat samples) analysis. The longest transcript detected was 23,144 bases. Gene expression across all the samples are shown as a distribution plot, scatter plot and distance matrix plot that correspond to the pairwise similarities between the samples (Figure 2). The data clearly indicates differential transcript expression levels between species and upon exposure to PPRV. With default settings for the Cuffdiff analysis, the genes that are differentially expressed (up- and down-regulated) across Control vs. PPRV infected in the PBMC from goat and cattle PBMC at a p value ≤ 0.05 are shown in Table 4.
Table 4.
Deseq Combination | Down-Regulated Transcripts | Up-Regulated Transcripts |
---|---|---|
Goat Cont. vs. Goat Inf. | 474 (19.0%) | 2017 (81.0%) |
Cattle Cont. vs. Cattle Inf. | 368 (68.0%) | 173 (32.0%) |
Goat Cont. vs. Cattle Cont. | 1574 (60.7%) | 1018 (39.3%) |
(Data represented from the bioinformatic analysis under project p4365).
3.3. PPRV Infection Induces Different Immune Responses in Goats and Cattle
The GO analysis indicated that a great number of transcripts were up and down-regulated in cattle compared to goat and selected GO terms of genes contributing to immune response, inflammatory response and defense response to viruses are depicted in Figure 3A,B. STRING analysis of the differential expression data revealed eight different closely associated protein–protein interaction (PPIs) networks. As expected, the network of genes identified to be interacting was different between cattle and goat PBMC after PPRV infection (Figure 4A,B).
Across goat-control and goat-infected samples we identified 12 genes that were up-regulated and play a role in host defense against viruses with only one gene (macrophage mannose receptor (MMR)), responsible for binding and transmission of virus by macrophages, down-regulated (Table 5). The differentially regulated genes includedthe type I interferon stimulated effector genes namely interferon-induced 17-KDa/15KDa (ISG 17/ISG 15), Interferon-Induced Protein 44 (IFI 44), 2′-5′-Oligoadenylate Synthetase 1 (OAS1X), Interferon Alpha Inducible 6 (IFI6), Interferon-Induced Protein with Tetratricopeptide Repeats 1 (IFIT1), IFIT2 and IFIT3,MyxovirusResistance 1 (Mx1) and Myxovirus Resistance 2 (Mx2); Radical S-Adenosyl Methionine Domain-Containing Protein 2 (RSAD2) also called Viperin (mediating antiviral responses); DEXH (Asp-Glu-X-His) Box Polypeptide 58 (DHX58) that leads to Retinoic Acid-Inducible Gene I (RIG-I); gene-mediated antiviral response and Phosphodiesterase 12 (PDE12) which is an 2′,5′-oligoadenylate degrading enzyme that regulates the 2′,5′-Oligoadenylate Synthetase (OAS) enzymes and RNase-L pathway (Table 5).
Table 5.
S.No | Gene ID | Gene | Goat Control FPKM Value | Goat Infected FPKM Value | log2 (Fold Change) |
---|---|---|---|---|---|
1 | ENSBTAG00000007554 | IFI6 | 685.79 | 2507.99 | 1.87 |
2 | ENSBTAG00000007881 | IFIT1 | 66.63 | 247.95 | 1.90 |
3 | ENSBTAG00000008471 | MX2 | 75.59 | 235.75 | 1.64 |
4 | ENSBTAG00000009768 | IFIT3 | 116.90 | 403.79 | 1.79 |
5 | ENSBTAG00000014707 | ISG15 | 725.86 | 2915.81 | 2.01 |
6 | ENSBTAG00000016061 | RSAD2 | 74.83 | 439.60 | 2.55 |
7 | ENSBTAG00000030913 | Mx1 | 266.28 | 1029.88 | 1.95 |
8 | ENSBTAG00000034349 | IFI44 | 41.14 | 151.84 | 1.88 |
9 | ENSBTAG00000034918 | IFIT2 | 144.59 | 588.48 | 2.03 |
10 | ENSBTAG00000037527 | OAS1X | 60.86 | 258.11 | 2.08 |
11 | ENSBTAG00000046580 | DHX58 | 74.18 | 224.04 | 1.59 |
12 | ENSBTAG00000015563 | PDE12 | 19.27 | 51.96 | 1.43 |
(Data represented from the bioinformatic analysis under project p4365).
However, in cattle control vs cattle infected, there were 22 genes that were up-regulated upon PPRV infection which included the type II interferon and the interferon gamma (IFNG); type I interferon stimulated effector genes namely ISG15, IFI44, OAS1X, IFI6, IFIT, IFIT2, IFIT3, Mx1 and Mx2, DHX58, OAS1X,2′-5′-Oligoadenylate Synthetase-1 (OAS1Y), Interferon-Induced Protein 44 Like (IFI44L), Interferon-Induced Transmembrane Protein 3 (IFITM3), RSAD2/Viperin, Interferon-Stimulated Exonuclease Gene 20 (ISG20), Interferon-Induced Protein with Tetratricopeptide Repeats 5 (IFIT5), DExD/H-Box Helicase 58 (DDX58), InterferonRegulator Factor 7 (IRF7), Interferon Induced With Helicase C Domain 1 (IFIH1) and PDE12; dsRNA binding induced serine/threonine protein kinase the Eukaryotic Translation Initiation Factor 2 Alpha Kinase 2 (EIF2AK2); and pro-inflammatory cytokine activated HECT and RLD Domain Containing E3 Ubiquitin Protein Ligase 5 (HERC5) (Table 6). The details on the role of the selected differentially expressed genes and their function in host responses against viral infection from published reports are listed in the Supplementary Table (Table S3).
Table 6.
S.No. | Gene ID | Gene | Cattle Control FPKM Value | Cattle Infected FPKM Value | log2 (Fold Change) |
---|---|---|---|---|---|
1 | ENSBTAG00000003366 | DDX58 | 25.853 | 165.535 | 2.67873 |
2 | ENSBTAG00000007554 | IFI6 | 85.1433 | 1240.16 | 3.86449 |
3 | ENSBTAG00000007881 | IFIT1 | 63.5862 | 530.603 | 3.06085 |
4 | ENSBTAG00000008142 | IFIH1 | 55.5351 | 152.708 | 1.45931 |
5 | ENSBTAG00000008471 | MX2 | 34.5429 | 605.862 | 4.13253 |
6 | ENSBTAG00000009768 | IFIT3 | 7.60867 | 365.035 | 5.58425 |
7 | ENSBTAG00000012529 | IFNG | 11.1059 | 39.2096 | 1.81988 |
8 | ENSBTAG00000014707 | ISG15 | 159.192 | 3860.52 | 4.59996 |
9 | ENSBTAG00000014762 | ISG20 | 90.9695 | 323.425 | 1.82998 |
10 | ENSBTAG00000016061 | RSAD2 | 41.7415 | 623.244 | 3.90024 |
11 | ENSBTAG00000017367 | IFIT5 | 22.1536 | 185.959 | 3.06937 |
12 | ENSBTAG00000020538 | HERC5 | 41.6011 | 155.056 | 1.89810 |
13 | ENSBTAG00000030913 | Mx1 | 50.5075 | 708.813 | 3.81084 |
14 | ENSBTAG00000030932 | IFI44L | 49.6875 | 259.9 | 2.38700 |
15 | ENSBTAG00000034349 | IFI44 | 35.618 | 295.417 | 3.05208 |
16 | ENSBTAG00000034918 | IFIT2 | 14.4535 | 126.911 | 3.13432 |
17 | ENSBTAG00000037527 | OAS1X | 56.6369 | 364.978 | 2.68799 |
18 | ENSBTAG00000039861 | OAS1Y | 42.7186 | 970.258 | 4.50543 |
19 | ENSBTAG00000046580 | DHX58 | 11.4804 | 144.685 | 3.65567 |
20 | ENSBTAG00000047680 | IRF7 | 98.2855 | 457.14 | 2.21759 |
21 | ENSBTAG00000008703 | EIF2AK2 | 24.6231 | 92.6854 | 1.91233 |
22 | ENSBTAG00000019015 | IFITM3 | 215.423 | 683.86 | 1.66653 |
(Data represented from the bioinformatic analysis under project p4365).
Among the 12 and 22 differentially expressed genes in goat and cattle that were identified from RNAseq data: In-vitro experiments were conducted to assess the expression levels of the IFI44, IFI6, IFIT1, IFIT2, IFIT3, ISG15, Mx1, Mx2, OAS1X, RSAD2, IRF7, DDX58, IFIH1, PDE12 and DHX58 by RT-qPCR. The interferon-induced genes, namely IFI44, IFI6, IFIT1, IFIT2, IFIT3, ISG15, Mx1, Mx2, OAS1X, RSAD2, IRF7, DDX58 and DHX58 were up-regulated in both species upon exposure to PPRV but with significantly higher levels in cattle which were also confirmed by RT-qPCR (Figure 5). However in goats, upon exposure to PPRV, the expression of Phosphodiesterase 12 (PDE12), a negative regulator of the 2′,5′-oligoadenylate system, is significantly increased, probably contributing to the decreased antiviral state induced by the interferons (IFNs) (Figure 5). The expression levels (FPKM) of the selected target genes identified by RNAseq correlated well with the RT-qPCR results, confirming the validity of the RNAseq data analysis (Figure 6; Supplementary Table, Table S4). We also have proposed a model depicting the roles of these differentially expressed target genes that contribute to the differential interferon levels which in turn regulates host responses resulting in differential PPRV replication in the goat and cattle (Figure 7).
4. Discussion
PPRV is capable of replicating in a wide variety of ruminant species but disease susceptibility is confined to small ruminants. Understanding the host factors that lead to viral pathogenesis and disease susceptibility or resistance will help to identify novel targets and inform better control strategies. In this study, we used RNAseq to study the increased susceptibility of goats to PPRV-induced disease compared to cattle by confirming increased viral replication and the identification and predicted function of differentially expressed genes induced during infection. Here we report the interaction of functionally annotated immune-related pathway genes that are differentially regulated between goat and cattle after exposure to PPRV.
In the past few years there has been a steady increase in the spread of PPRV across different countries and around 63% of the small ruminants globally may be under threat [18]. PPRV is considered small ruminant specific, with domesticated cattle and buffalo described as dead-end hosts. However, several surveillance programs have reported the presence of PPRV-specific antibodies in atypical hosts such as domesticated cattle (67%), buffalo (41%) and camel [11,19,20]. The potential of the virus to overcome innate resistance in these atypical hosts to result in evident clinical signs or disease transmission has been little studied [12,21]. The toll-like receptors (TLR) 7 and TLR3 play a major role in innate recognition of ssRNA viruses. Upon sensing the viral pathogen associated molecular patterns (PAMPS), a complex network of intra-cellular signaling pathways are activated by these TLRs which results in the production of several antiviral cytokines. Previous data from our laboratory clearly provides evidence that the viral recognition by these innate immune receptors and the subsequent cytokine profiles results in a 2log10 lower PPR virus titre in the PBMC of buffaloes when compared with goats [17]. Experiments on the replication kinetics of PPRV in cattle and goat PBMC revealed an increased virus titre and fold change in PPRV M gene RNA expression (0.2 log10 titre and 0.13 fold increase respectively) as early as 24 h post infection (PI) in goats (A 1.2 log10 higher virus titre and 3.81 fold increase in expression at 120 h PI in goat PBMC; for details refer to Supplementary Information—PPRV replication kinetics).
The genetic basis underlying differential host susceptibility or resistance is highly complex. Methods that enable the identification and analysis of gene interaction networksin a single experiment offer a powerful approach to understanding these complex processes. Systems biology approaches not only investigate the role of multiple genes contributing to a phenomenon but also generate information on their behavior and relationships in a quantitative, integrative and comprehensive manner [22]. High-throughput sequencing generated RNAseq data can provide gene expression profiles to identify genes likely to contribute to host-virus interactions and potentially to differential resistance/susceptibility across different species [23].
Among the cytokines, the interferons (IFNs) provide an anti-viral state to the host cells as well as help in modulating adaptive immune responses. Type I IFNs (IFNα/β) generate ananti-viral state by binding to the IFNα/β receptor which activates the transcription of interferon-stimulated genes (ISGs) via the JAK/STAT pathway while. Type II IFN (IFNγ) functions through a different receptor (IFNGR) to induce gamma activated factor (GAF) that activates the transcription of a distinct subset of cellular genes result in an antiviral state [24,25]. In addition to the interferon-induced genes, we also selected other significantly differentially regulated immune related genes with roles in the innate immune response, inflammatory response and defense response (Figure 3A,B) [17]. The classical inflammatory cytokines such as IFNβ, IFNγ, IL-4, IL-1β, IL-8, IL-10, IL-6 and IL-12 are induced in goats upon PPRV infection [26,27] even though the PPRV V protein possess the ability to inhibit the IFN signaling [28,29,30]. In experiments with the Sungri/96 PPRV vaccine virus, IFN-α/β mRNA were not detected after the infection of PBMC [31] and evasion of IFN-induced antiviral effects by PPRV have been shown to occur through miRNA mediated regulation of IRF3 and IRF7 [32]. In contrast, studies with a virulent PPRV strain demonstrated that genes within the interferon and RIG-1 like receptor signaling pathway, IRF-7 and STAT-1 that regulate the expression of ISGs, were active in lymphocytes [33]. Our previous report also indicates the contribution of TLR7 mediated higher IFN alpha induction as a factor for the lower replication of PPRV in cattle PBMC [17].
Viral infection-induced interferons induce an exclusive and moderately overlapping set of interferon stimulated genes (ISG) and studies have identified 50 to 1000 ISGs (using microarrays) that are typical to some cells types with effector functions limited to the classical ISGs, namely protein kinase (PKR; also known as eukaryotic translational initiation factor 2-alphase kinase -EIF2AK2), Myxovirus Resistance Protein 1 (MX1), 2′-5′-oligoadenylate synthetase 1 (OAS1), Tripartite Motif Containing 5 (TRIM5), Interferon-stimulated gene 15 (ISG15), adenosine deaminase acting on RNA (ADAR), interferon-induced transmembrane protein 1/2/3 (IFITM1/2/3 also called CD225), Tetherin (also known as BST2 or CD17), Viperin (also known as Radical S-Adenosyl Methionine Domain Containing 2 -RSAD2) [34,35] and ATP-dependent dsRNA helicase DHX58 also known as RIG-I-like receptor LGP2 (RLR) [36]. Up-regulation of the ISGs (ISG15, Mx1, Mx2, RSAD2, IFIT3 and IFIT5) that play a role in antiviral response and the viral sensors MDA5, LGP2 and RIG1 were found to up-regulated in lymphocytes upon exposure to a virulent strain of PPRV [33]. Our RNAseq data also reveal that the IFN type I responses are highly up-regulated in cattle. This increased type I interferon results in up-regulation of the ISG effector molecules such as Mx, OAS, PKR and related genes in cattle which have a crucial role to play in viral defense. One of the major effects of the IFN is induction of Oligoadenylate synthetase (OAS) that is capable of polymerizing ATP in a template-dependent fashion. OAS results in 2′,5′-linked oligoadenylate polymers (2-5A) which is not found in mRNA and DNA, resulting in the activation of RNase-L that leads to cleavage of viral genomes. This pathway is also regulated by enzymes encoded by virus and the host that degrades 2-5A. One such enzyme is phosphodiesterase 12 (PDE12) which degrades 2-5A and thus inhibition/decreased levels of PDE12 might up-regulate viral-infection-induced OAS/RNase-L pathway resulting in increased resistance to viral pathogens. Our results indicated that PDE12, a negative regulator of the innate immune response, is up-regulated in goats which could be a major reason for the decreased resistance to viral replication.
This host antiviral response is also potentiated by the increased levels of the interferon-induced IFIT family genes (IFIT1, IFIT2, IFIT3, IFIT5) in cattle (Table 6). The up-regulation of these genes was confirmed in the RT-qPCR experiments. In addition, it was observed that the DHX58/ RLR gene is also up-regulated in cattle. DHX58/ RLR induces RIG-I which helps in intra-cytoplasmic sensing of dsRNA and results in type I interferon release through the IRF-7 pathway. The stimulation of the IRF-7 gene has been shown toprovide host defense against viral infection by inducing Viperin/RSAD2 and our data shows that Viperin/RSAD2 are highly up-regulated in cattle. Gene profiling in IFN-α/βR-deficient mice indicates that Viperin is induced by several different viruses, dsRNA and poly-dAdT [37,38]. This pathway inhibits replication of Flaviviruses (HCV), West Nile virus (WNV) and Dengue virus, herpesviruses (HCMV), a paramyxovirus (Sendai virus), a rhabdovirus (VSV) an Orthomyxovirus (Influenza A virus) and a retrovirus (HIV-1) [39,40,41,42,43].
The fundamental aim of our study was to better understand differential resistance/ susceptibility to PPRV between small and large ruminants. Earlier reports from our work indicated that PPRV induced increased interferon levels in cattle and buffalo and were likely to be a major factor causing decreased PPRV replication. This study reveals a complex interaction of ISGs and their effector molecules is likely a major factor leading to host defense and decreased PPRV replication in cattle, confirming our earlier report. In summary, these results indicate the potential role of ISGs and their interacting proteins in the differential replication of PPRV in PBMC between goats and cattle. If the host immune responses in small ruminants are sufficiently suppressed, especially the interferon-stimulated genes, this could in part explain clinical disease in particular breeds and species. Further in-vitro experiments are being planned on selected target genes identified using a siRNA/ CRISPR Cas9 system approach and over expression to understand their contribution to the differential replication of PPRV between these two species. In addition, efforts to generate small molecule inhibitors to some of the targets identified, e.g., PDE12, could help in improving the immune responses to PPRV in the susceptible species.
Acknowledgments
The authors would like to acknowledge the facilities provided by Tamil Nadu Veterinary and Animal Sciences University.
Supplementary Materials
The following are available online at https://www.mdpi.com/1999-4915/12/4/463/s1. Supplementary information: PPRV replication kinetics in goat and cattle PBMC. Figure S1: Transcript annotation of the goat and cattle transcripts that revealed BlastX matches to NCBI database (both as e-value and similarity distribution as percentage). Functional annotation of the transcriptome with BlastX matches to different GO category - Biological process; Cellular component and Molecular function (The top 15 GO terms are depicted in each of the above category). Table S1: List of software’s used for bioinformatic analysis of the data generated in the study. Predicted proteins from BLASTX were annotated against NCBI, UniProt, Pathway and other databases. Table S2: Functional annotation of the transcriptome with BlastX matches to different GO category. The details on the Gene Ontology ID, GO terms and number of transcripts are listed. The total number of GO different terms identified across biological process, molecular function and cellular component included 33,412 (with 118,736 transcripts), 11,323 (with 71,161 transcripts) and 14,076 (with 81,646 transcripts) respectively. Table S3: Details on the functional role of the differentially expressed transcripts in host response against viral infection identified in the study. Table S4: Relative expression levels of the differentially expressed transcripts in response to viral infection (based on the RNAseq data) using SYBR Green chemistry in of goat and cattle PBMCs infected with PPRV at 1 MOI (The depicted Ct values are mean of five samples tested; ∆Ct = target gene Ct- endogenous Ct; ∆∆Ct = ∆Ct of infected- ∆Ct of control; Fold change = 2−∆∆Ct). Table S5: The details on the PPIs identified in the STRING analysis of the differentially expressed targets in goat and cattle upon PPRV infection. The list of STRING interactions are listed in goat and cattle on separate sheets. The details on the scores for the co-expression, experimentally determined interaction, database annotation, text mining and combined score are used for the different colors of the nodes in the Figure 4A,B.
Author Contributions
Conceptualization, K.G.T., G.D.R. and S.P.; Data curation, K.G.T. and R.M.P.; Formal analysis, K.G.T. and R.M.P.; Funding acquisition, G.D.R., J.A.H. and S.P.; Methodology, K.G.T. and R.M.P.; Resources, G.D.R. and A.T.; Validation, K.G.T. and R.M.P.; Writing—original draft, K.G.T., G.D.R., J.A.H. and S.P.; Writing—review and editing, K.G.T., G.D.R., A.T., J.A.H. and S.P. All authors have read and agreed to the published version of the manuscript.
Funding
This work was financially supported by Dept. of Biotechnology, GOI, New Delhi, India grant (BT/IN/Indo-UK/FADH/50/GDR/2013) and UKRI-BBSRC FADH grant (BB/L004801/1). Satya Parida and John Hammondacknowledge funding from BBSRC (Grant codes: BBS/E/I/00007030, BBS/E/I/00007031 and BBS/E/I/00007036). Satya Parida and John Hammond are visiting professors at the Royal Veterinary College (RVC), London and University of Edinburgh, respectively. Satya Parida is a Jenner investigator at the Jenner Institute, Oxford University.
Conflicts of Interest
The authors declare that there exists no conflict of interest.
References
- 1.Lefevre P.C., Diallo A. Peste des petits ruminants. Rev. Sci. Tech. Off. Int. Epiz. 1990;9:951–965. doi: 10.20506/rst.9.4.532. [DOI] [PubMed] [Google Scholar]
- 2.Shaila M.S., Purushothaman V., Bhavasar D., Venugopal K., Venkatesan R.A. Peste des petits ruminants of sheep in India. Vet. Rec. 1989;125:602. [PubMed] [Google Scholar]
- 3.Kulkarni D.D., Bhikane A.U., Shaila M.S., Varalakshmi P., Apte M.P., Narladkar B.W. Peste des petits ruminants in goats in India. Vet. Rec. 1996;138:187–188. doi: 10.1136/vr.138.8.187. [DOI] [PubMed] [Google Scholar]
- 4.Nanda Y.P., Chatterjee A., Purohit A.K., Diallo A., Innui K., Sharma R.N., Libeau G., Thevasagayam J.A., Burning A., Kitching R.P., et al. The isolation of Peste des petitsruminants virus from Northern India. Vet. Microbiol. 1996;51:207–212. doi: 10.1016/0378-1135(96)00025-9. [DOI] [PubMed] [Google Scholar]
- 5.Shaila M.S., Peter A.B., Varalakshmi P., Apte M.P., Rajendran M.P., Anbumani S.P. Peste des petits ruminants in Tamilnadu goats. Indian Vet. J. 1996;73:587–588. [Google Scholar]
- 6.Saravanan P., Sen A., Balamurugan V., Rajak K.K., Bhanuprakash V., Palaniswami K.S., Nachimuthu K., Thangavelu A., Dhinakarraj G., Hegde R., et al. Comparative efficacy of Peste des petits ruminants (PPR) vaccines. Biologicals. 2010;38:479–485. doi: 10.1016/j.biologicals.2010.02.003. [DOI] [PubMed] [Google Scholar]
- 7.Couacy-Hymann E., Bodjo C., Danho T., Diallo G.L.A. Evaluation of the virulence of some strains of Peste-des-petits-ruminants virus (PPRV) in experimentally infected West African dwarf goats. Vet. J. 2007;173:178–183. doi: 10.1016/j.tvjl.2005.08.020. [DOI] [PubMed] [Google Scholar]
- 8.Singh R.P., Saravanan B.P., Dhar P., Shah L.C., Bandyopadhyay S.K. Development of a monoclonal antibody based competitive-ELISA for detection and titration of antibodies to Peste des petites ruminants (PPR) virus. Vet. Microbiol. 2004;98:3–15. doi: 10.1016/j.vetmic.2003.07.007. [DOI] [PubMed] [Google Scholar]
- 9.Delil F., Asfaw Y., Gebreegziabher B. Prevalence of antibodies to Peste des petits ruminants virus before and during outbreaks of the disease in Awash Fentale district; Afar; Ethiopia. Trop. Anim. Health Prod. 2012;44:1329–1330. doi: 10.1007/s11250-012-0110-8. [DOI] [PubMed] [Google Scholar]
- 10.Anderson J., McKay A. The detection of antibodies against Peste des petits ruminants virus in cattle; sheep and goats and the possible implications to rinderpest control programmes. Epidemiol. Infect. 1994;112:225–231. doi: 10.1017/S0950268800057599. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Khan H.A., Siddique M., Sajjad U.R., Abubakar M., Ashraf M. The detection of antibody against Peste des petits ruminants virus in sheep; goats; cattle and buffaloes. Trop. Anim. Health Prod. 2008;40:521–527. doi: 10.1007/s11250-008-9129-2. [DOI] [PubMed] [Google Scholar]
- 12.Mornet P., Orue J., Gillbert Y., Thiery G.S.M. La peste des petits Ruminants en Afrique occidentale française ses rapports avec la Peste Bovine. Rev. Elev. Med. Vet. Pays Trop. 1956;9:313–342. doi: 10.19182/remvt.6969. [DOI] [Google Scholar]
- 13.Govindarajan R., Koteeswaran A., Venugopalan A.T., Shyam G., Shaouna S., Shail M.S., Ramachandran S. Isolation of Pestes des petits ruminants virus from an outbreak in Indian buffalo (Bubalus bubalis) Vet. Rec. 1997;141:573–574. doi: 10.1136/vr.141.22.573. [DOI] [PubMed] [Google Scholar]
- 14.Roger F., Guebre Y.M., Libeau G., Diallo A., Yigezu L.M., Yilma T. Detection of antibodies of rinderpest and Peste des petits ruminants viruses (Paramyxoviridae; Morbillivirus) during a new epizootic disease in Ethiopian camels (Camelusdromedarius) Rev. Med. Vet. 2001;152:265–268. [Google Scholar]
- 15.Pawar R.M., Raj G.D., Balachandran C. Relationship between the level of signaling lymphocyte activation molecule mRNA and replication of Peste des petits ruminants virus in peripheral blood mononuclear cells of host animals. ActaVirol. 2008;52:231–236. [PubMed] [Google Scholar]
- 16.Birch J., Juleff N., Heaton M.P., Kalbfleisch T., Kijas J., Bailey D. Characterization of ovine nectin-4; a novel Peste des petits ruminants virus receptor. J. Virol. 2013;87:4756–4761. doi: 10.1128/JVI.02792-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Dhanasekaran S., Biswas M., Ambothi R., Ramya V.R., Raj G.D., Tirumurugaan K.G., Raja A., Kataria R.S., Parida S., Subbiah E. Toll-Like Receptor Responses to Peste des petits ruminants Virus in Goats and Water Buffalo. PLoS ONE. 2014;9:1609–1611. doi: 10.1371/journal.pone.0111609. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Baron M.D., Diallo A., Lancelot R., Libeau G. Chapter One—Peste des Petits Ruminants Virus. In: Margaret Kielian K.M., Thomas C.M., editors. Advances in Virus Research. Volume 95. Academic Press; Cambridge, MA, USA: 2016. pp. 1–42. [DOI] [PubMed] [Google Scholar]
- 19.Ozkul A., Akca Y., Alkan F., Barrett T., Karaoglu T., Daglap S.B., Anderson J., Yesilbag K., Cokcaliskan C., Genacy A., et al. Prevalence; distribution and host range of peste des petitsruminants virus; Turkey. Emerg. Infect. Dis. 2002;8:708–712. doi: 10.3201/eid0807.010471. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Abraham G. Antibody seroprevalences against Peste des petitsruminants virus in camels; cattle; goats and sheep in Ethiopia. Prev. Vet. Med. 2005;70:51–57. doi: 10.1016/j.prevetmed.2005.02.011. [DOI] [PubMed] [Google Scholar]
- 21.Khalafalla A.I., Saeed I.K., Ali Y.H., Abdurrahman M.B., Kwiatek O., Libeau G., Obeida A.A., Abbas Z. An outbreak of peste des petits ruminants (PPR) in camels in the Sudan. Acta Trop. 2010;116:161–165. doi: 10.1016/j.actatropica.2010.08.002. [DOI] [PubMed] [Google Scholar]
- 22.Sharon D., Chenb R., Snyderb M. Systems biology approaches to disease marker discovery. Dis. Markers. 2010;28:209–224. doi: 10.1155/2010/152759. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Morrison-Smith S., Boucher C., Bunt A., Ruiz J. Elucidating the role and use of bioinformatics software in life science research; Proceedings of the 2015 British HCI Conference; Lincoln, UK. 13–17 July 2015; pp. 230–238. [Google Scholar]
- 24.Platanias L.C. Mechanisms of type-I- and type-II-interferon-mediated signalling. Nat. Rev. Immunol. 2005;5:375–386. doi: 10.1038/nri1604. [DOI] [PubMed] [Google Scholar]
- 25.Randall R.E., Goodbourn S. Interferons and viruses, an interplay between induction; signalling; antiviral responses and virus counter measures. J. Gen. Virol. 2008;89:1–47. doi: 10.1099/vir.0.83391-0. [DOI] [PubMed] [Google Scholar]
- 26.Atmaca H.T., Kul O. Examination of epithelial tissue cytokine response to natural Peste des petits ruminants virus (PPRV) infection in sheep and goats by immunohistochemistry. Histol. Histopathol. 2012;27:69–78. doi: 10.14670/HH-27.69. [DOI] [PubMed] [Google Scholar]
- 27.Baron J., Bin-Tarif A., Herbert R., Frost L., Taylor G., Baron M.D. Early changes in cytokine expression in Peste des petits ruminants disease. Vet. Res. 2014;45:22. doi: 10.1186/1297-9716-45-22. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Fontana J.M., Bankamp B., Bellini W.J., Rota P.A. Regulation of interferon signaling by the C and V proteins from attenuated and wild-type strains of measles virus. Virology. 2008;374:71–81. doi: 10.1016/j.virol.2007.12.031. [DOI] [PubMed] [Google Scholar]
- 29.Caignard G., Bourai M., Jacob Y., Tangy F., Vidalain P.O. Inhibition of IFN-alpha/ beta signalling by two discrete peptides within measles virus V protein that specifically bind STAT1 and STAT2. Virology. 2009;383:112–120. doi: 10.1016/j.virol.2008.10.014. [DOI] [PubMed] [Google Scholar]
- 30.Manjunath S., Kumar G.R., Mishra B.P., Mishra B., Sahoo A.P., Joshi C.G., Tiwari A.K., Rajak K.K., Janga S.C. Genomic analysis of host- Peste des petits ruminants vaccine viral transcriptome uncovers transcription factors modulating immune regulatory pathways. Vet. Res. 2015;46:15. doi: 10.1186/s13567-015-0153-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Ma X., Yang X., Nian X., Zhang Z., Dou Y., Zhang X., Luo X., Su J., Zhu Q., Cai X. Identification of amino-acid residues in the V protein of peste des petits ruminants essential for interference and suppression of STAT-mediated interferon signaling. Virology. 2015;483:54–63. doi: 10.1016/j.virol.2015.03.039. [DOI] [PubMed] [Google Scholar]
- 32.Qi X., Wang T., Xue Q., Li Z., Yang B., Wang J. MicroRNA expression profiling of goat peripheral blood mononuclear cells in response to Peste des petits ruminants virus infection. Vet. Res. 2018;49:62. doi: 10.1186/s13567-018-0565-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Wani S.A., Sahu A.R., Khan R.I.N., Pandey A., Saxena S., Hosamani N., Malla W.A., Chaudhary D., Kanchan S., Sah V., et al. Contrasting Gene Expression Profiles of Monocytes and Lymphocytes From Peste des petits ruminants Virus Infected Goats. Front. Immunol. 2019;10:1463. doi: 10.3389/fimmu.2019.01463. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.De Veer M.J., Holko M., Frevel M., Walker E., Der S., Paranjape J.M., Silverman R.H., Williams B.R.G. Functional classification of interferon-stimulated genes identified using microarrays. J. Leukoc. Biol. 2001;69:912–920. [PubMed] [Google Scholar]
- 35.Sarasin-Filipowicz M., Oakeley E.J., Duong F.H.T., Christen V., Terracciano L., Filipowicz W., Heim M.H. Interferon signaling and treatment outcome in chronic hepatitis C. Proc. Natl. Acad. Sci. USA. 2008;105:7034–7039. doi: 10.1073/pnas.0707882105. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Cui S., Eisenächer K., Kirchhofer A., Brzózka K., Lammens A., Lammens K., Fujita T., Conzelmann K.-K., Krug A.B., Hopfner K.-P. The C-terminal regulatory domain is the RNA 5’-triphosphate sensor of RIG-I. Mol. Cell. 2008;29:169–179. doi: 10.1016/j.molcel.2007.10.032. [DOI] [PubMed] [Google Scholar]
- 37.Olofsson P.S., Jatta K., Wågsäter D., Gredmark S., Hedin U., Paulsson-Berne G., Söderberg-Nauclér C., Hansson G.K., Sirsjö A. The antiviral cytomegalovirus inducible gene 5/viperin is expressed in atherosclerosis and regulated by pro-inflammatory agents. Arterioscler. Thromb. Vasc. Biol. 2005;25:e113–e116. doi: 10.1161/01.ATV.0000170130.85334.38. [DOI] [PubMed] [Google Scholar]
- 38.Severa M., Coccia E.M., Fitzgerald K.A. Toll-like receptor-dependent and -independent viperin gene expression and counter-regulation by PRDI-binding factor-1/BLIMP1. J. Biol. Chem. 2006;281:26188–26195. doi: 10.1074/jbc.M604516200. [DOI] [PubMed] [Google Scholar]
- 39.Jiang D., Guo H., Xu C., Chang J., Gu B., Wang L., Block T.M., Guo J.-T. Identification of Three Interferon-Inducible Cellular Enzymes That Inhibit the Replication of Hepatitis C Virus. J. Virol. 2008;82:1665–1678. doi: 10.1128/JVI.02113-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Jiang D., Weidner J.M., Qing M., Pan X.B., Guo H., Xu C., Zhang X., Birk A., Chang J., Shi P.Y., et al. Identification of five interferon-induced cellular proteins that inhibit West Nile virus and dengue virus infections. J. Virol. 2010;84:8332–8341. doi: 10.1128/JVI.02199-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Rivieccio M.A., Suh H.S., Zhao Y., Zhao M.-L., Chin K.C., Lee S.C., Brosnan C.F. TLR3 ligation activates an antiviral response in human fetal astrocytes, a role for viperin/ cig5. J. Immunol. 2006;177:4735–4741. doi: 10.4049/jimmunol.177.7.4735. [DOI] [PubMed] [Google Scholar]
- 42.Stirnweiss A., Ksienzyk A., Klages K., Rand U., Grashoff M., Hauser H., Kröger A. IFN regulatory factor-1 bypasses IFN-mediated antiviral effects through viperin gene induction. J. Immunol. 2010;184:5179–5185. doi: 10.4049/jimmunol.0902264. [DOI] [PubMed] [Google Scholar]
- 43.Wang X., Hinson E.R., Cresswell P. The interferon-inducible protein viperin inhibits influenza virus release by perturbing lipid rafts. Cell Host Microbe. 2007;2:96–105. doi: 10.1016/j.chom.2007.06.009. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.